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Pressure elevation slows the fibroblast response to
wound healing
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Objective:Chronic venous insufficiency and venous ulceration are consequences of elevated pressure within affected limbs.
We hypothesized that wounded cells maintained at different atmospheric pressures heal at different rates and that
pressure would adversely affect the processes necessary for wound healing.
Methods:We have developed an in vitro model that replicates venous hypertension in a unique pressurized incubator using
neonatal fibroblasts. Neonatal fibroblasts grown to confluence were woundedwith a standardized linear incision and then
placed in a unique pressure incubator at atmospheric pressure, atmospheric pressure plus 30 mm Hg, atmospheric
pressure plus 60 mm Hg, and atmospheric pressure plus 120 mm Hg. Cells were observed daily until complete healing
of the wound occurred. Twelve to 18 hours after wounding, proliferating cell nuclear antigen analysis was done by
immunocytochemistry.
Results:Wounds at atmospheric pressure plus 30 mmHgwere healed by day 3, those at atmospheric pressure plus 60 mm
Hg by day 4, and those grown at atmospheric pressure plus 120 mmHg took>4 days for complete healing. Significantly
less proliferating cell nuclear antigen activity was present in cells grown at atmospheric pressure plus 60 mm Hg (P <
.0001) and atmospheric pressure plus 120 mm Hg (P < .02). Wound edge fluorescence analysis demonstrated less
fluorescence in each group compared with atmospheric pressure.
Conclusions: In this model of wound healing under pressure, neonatal fibroblasts grown to confluence and given a
standardized wound displayed characteristics consistent with delayed healing. Elevated pressure has a role in the delayed
migration and proliferation seen in this model.
Clinical Relevance: The elevated pressure in patients with venous insufficiency causes their wounds to heal less quickly.
Understanding and quantifying the physiology and role of elevated tissue pressure due to venous hypertension will lead
to a better understanding of wound healing in these patients. ( J Vasc Surg 2005;42:546-51.)Venous ulceration is a consequence of chronic venous
hypertension,1 and although the degree of elevated pres-
sure is related to the risk of ulceration,2,3 the reason why
healing is delayed remains unknown.1 Our previous work
has shown that fibroblasts isolated from venous ulcers have
slow growth rates, altered morphologies, and elevated lev-
els of senescence markers.4,5 Subsequent in vitro studies
have shown that when neonatal fibroblasts (NNF) are
incubated in a unique pressurized incubator,6,7 the pheno-
types of these neonatal cells become similar to cells isolated
from venous ulcers in appearance, growth characteristics,
and levels of senescence markers. This process may be
explained by a premature aging phenomenon.7
The present study attempts to further characterize the
behavior of fibroblasts when exposed to elevated pressure.
When NNF are grown under pressure, the proportion of
fibroblasts positive for senescencemarkers is directly related
to the degree of pressure. In addition, cellular replication is
suppressed by pressure elevation.7 In this study, we adapted
a fibroblast wound-healing model8,9 for use with our pres-
surized incubator. We hypothesized that processes neces-
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546sary for wound healing in this model (migration, prolifera-
tion) would be delayed by pressure.
MATERIAL AND METHODS
This study was approved by the University of Vermont
Committee on Human Research (Protocol CRMS 02-
156), and all procedures were in accordance with the
ethical standards of the committee as well as the Helsinki
Declaration of 1975.
Pressure incubator. A specially constructed incubator
built at the University of Vermont was used in this investi-
gation.6,7 An autoclave unit was modified to control tem-
perature, atmospheric pressure, humidity, and levels of
carbon dioxide. Incubator pressure was measured by a
solid-state pressure sensor that worked in concert with a
compressor to control incubator pressure. Carbon dioxide
calibration was done at the start of an experiment, and the
carbon dioxide level was controlled by a sensor throughout
the incubation period. The pressure in the incubator was
maintained with a continuous monitoring of carbon diox-
ide and maintenance of a 6% level at all pressures studied.
The temperature was regulated by a thermostat-con-
trolled heating element combined with a fan for air circu-
lation. Experiments were performed at a temperature of
37°C, and the relative humidity in the chamber was deter-
mined by a solid-state sensor. The pH of the media was
monitored during incubation.
Fibroblast harvest and culture. NNF were obtained
(with parental permission) from infants undergoing cir-
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described.4,6,7 Foreskin specimens were treated with a
5-minute povidone-iodine bath followed by a 5-minute
bath in 70% ethanol. The tissue was incubated overnight at
4°C in trypsin solution, followed by a 2-hour incubation at
37°C in the same solution, allowing for sterile separation of
the dermal tissue from epidermal and adipose tissue. The
dermal tissue was then morselized and placed in etched
tissue culture dishes (Fisher, Pittsburgh, Pa) with Dulbecco
Modified Eagle Medium (DMEM) with 10% calf serum
(CS) and antibiotic solution (penicillin G, amphotericin B
as Fungizone, and streptomycin) (Bristol-Squibb Meyers,
Bristol, England). No growth factors were added to the
media. Light microscopy was used to monitor cultures for
contamination. Once the NNF reached 60% to 80% con-
fluence (2 to 4 weeks), they were trypsinized from the
culture dishes and used immediately for experimentation,
or frozen and stored. All first-passage cells were used in
these experiments.
Experimental design. Cells were grown to confluence
at atmospheric pressure (ATM) as the control, ATM plus 30
mmHg (ATM30), ATMplus 60mmHg (ATM60), and
ATM plus 120 mmHg (ATM120). At each pressure, cells
were fed media (DMEMplus 10% CS). After wounding, cells
were observed daily until confluence was reached.
Wounding of cells. The technique was modified from
that described previously.8,9 A sterilized round cover glass
was placed in each 35-mm tissue culture dish used (Fisher
Scientific). Cells were plated at a density of 50,000 cells per
plate and grown to confluence. When confluence was
reached, cells were then wounded by using a sterile plastic
1000-L pipette tip to scrape a single linear cell-free area.
The medium was aspirated to remove cellular debris, fresh
complete medium was added, and plates were placed into
appropriate incubators at either ATM or specifically in-
creased atmospheric pressures.
Wound healing. Images of the wound and wound
Fig 1. Images of neonatal fibroblasts (4) at atmosphe
after wounding (arrows delineate wound edge).edge were recorded immediately before and after wound-ing by light microscopy (Olympus IX70, Tokyo, Japan) at
4 and 10 magnification. Images were then recorded
every 24 hours until the wound was filled in with fibroblasts
and had healed. Images were then analyzed using Meta-
Morph (Universal Imaging Corp., Downingtown, Pa).
The program was calibrated before each image was ana-
lyzed by selecting the correct microscope and magnifica-
tion used in obtaining the images. Then, a minimum of 10
measurements of the distance from wound edge to wound
edge was recorded for each time point. The measurements
from each time point were then averaged, and the percent-
age of healing in the original wound was determined.
Immunocytochemistry. Twelve to 18 hours after
wounding, the cells were washed twice with phosphated
buffer solution (PBS) and fixed and permeablized with
–20°C methanol for 1 hour on ice. It was found that
waiting 18 hours after wounding resulted in the inability
to locate the wound in plates that were placed in the normal
atmospheric pressure incubator. The cells were then
washed twice for 5 minutes in PBS and incubated in a
solution of 0.1% Tween-20 in PBS at room temperature for
15 minutes. Subsequently, the cells were washed with
0.001% bovine albumin (BSA) in PBS four times (for 5
minutes each time) and then incubated in proliferating cell
nuclear antigen (PCNA) (BDBiosciences Pharmingen, San
Diego, Calif) (1:1000 dilution) in 0.1% BSA in PBS on a
rocker overnight at 4°C. The next day, the cells underwent
a series of washes as follows: 2 20minutes in 2.0%milk in
0.1% Tween-20 in PBS at room temperature, 4  5 min-
utes in PBS, and 2  5 minutes in 0.001% BSA in PBS.
The cells were then incubated in the dark at room
temperature for 30 minutes with a fluorescein-conjugated
goat antimouse immunoglobulin G polyclonal antibody at
a 1:1000 dilution (Santa Cruz Biotechnology Inc., Santa
Cruz, Calif). After 4  5-minute washes in PBS, cells were
counterstained with YOYO (Molecular Probes, Eugene,
Ore) 1:10,000/RNAse for 30 minutes at 37°C (atmo-
nfluent cells (A) before wounding and (B) immediatelyre. Cospheric carbon dioxide) to allow visualization of the nuclei.
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confluence and before wounding at (A) atmosphere (ATM), (B)ATMplus 30mmHg, (C)ATMplus 60mmHg, and
(D) ATM plus 120 mmHg. NNF 2 days after wounding are shown after growing at (E) ATM, (F) ATM plus 30 mm
Hg, (G) ATM plus 60 mm Hg, and (H) ATM plus 120 mm Hg.
Con
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mounted onto slides after 3  7-minute washes in PBS.
PCNA expression was visualized using a BioRad MRC
1024ES Confocal Laser Scanning Imaging System (Her-
cules, Calif), and an Olympus BX50 microscope (Tokyo,
Japan). Corel Photo-Paint 11 (Corel, Ottawa, Ontario,
Canada) was later used to quantify mean nuclear fluores-
cence of the cells.
Statistical analyses. All data are expressed as the mean
 standard deviation. For PCNA and wound edge analysis,
each series of experiments was run with a control group
(ATM) and statistical analyses were done for each experi-
ment to avoid the confounding factor of intraexperimental
error. Each pressure condition was compared to the ATM
control from the same experiment. When more than one
experiment was run per condition, two-way analysis of
variance was used to control for interexperiment variability,
while two-sample t tests were used when there was only one
experiment. Because each comparison was a separate exper-
iment, no adjustment for multiple comparisons was
made.10
Fig 2.
Fig 3. Time to complete (gross) wound healing for each experi-
mental group.RESULTS
Images of cells grown at ATM before and immediately
after wounding are shown in Fig 1. Fig 2 shows cells in each
experimental group before wounding and after wounding
on day 2. All cells grown at ATMwere healed completely by
day 2 after wounding, wounds at ATM30 were healed by
day 3, those at ATM60 at day 4, and those grown at
ATM120 took 4 days for complete healing (Fig 3).
Results from the PCNA analysis are summarized in
Table I. Cells grown at both ATM60 and ATM120 had
significantly less PCNA staining than cells grown at ATM.
Wound edge fluorescence analysis demonstrated less
fluorescence in each group compared with ATM, but at
ATM120, this did not reach significance, probably be-
cause of greater variation in the data (Table II).
DISCUSSION
Ulcerations that occur as a consequence of venous
insufficiency are slow to heal, although the exact mecha-
nism of the delay is unknown.1 Falanga and Eaglstein11
suggested that macromolecules leak into the dermis as a
result of venous hypertension. Thesemolecules bind or trap
growth factors and matrix material, which is then unavail-
able for tissue repair. Thomas et al12 have suggested that
white blood cells accumulate in the microcirculation of
patients with venous insufficiency, aggravating the trophic
changes in the skin. Others have suggested that matrix
metalloproteinases, produced by white blood cells, are
responsible for creating a local ulcerogenic environ-
ment.13,14
Although it is likely that the microenvironment influ-
ences the delayed wound healing of venous ulcers, one clear
factor in the development and delayed healing is the pro-
gressive venous hypertension associated with severe venous
insufficiency.2,3,15 Nicolaides et al3 have shown a direct
correlation between the level of venous hypertension and
tinuedthe incidence of ulceration.
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venous ulcer, we have developed a unique pressurized
incubator that allows us to examine the effects of pressure
upon healthy fibroblast cultures.6,7 Previous work sug-
gested that cells grown under pressure replicate the mor-
phologic changes and delayed growth seen with fibroblasts
isolated from patients with venous ulcers.4,6,7 Our studies
suggest that NNF grown under pressure have increased
numbers of senescent cells,7 similar to what we have ob-
served in clinical ulcer specimens,4 and that this premature
aging response is one of the reasons for delayed healing.
Some authors have suggested that the delayed healing seen
in vivo in chronic venous insufficiency is mediated by
transforming growth factor-16; however, this potential
mediator did not have any effect on fibroblast cultures
grown under pressure.7
In this study, we adapted a wound-healing model8,9 for
use in the pressurized incubator to evaluate the ability of
fibroblasts to respond to a wounding stimulus, replicating
the clinical situation. Our hypothesis that cells grown under
elevated pressure would show evidence of delayed healing
was validated, adding another similarity of this model sys-
tem to the clinical condition. In addition to the significant
increase in time to complete healing, PCNA production
Table I. Proliferating cell nuclear antigen results
Group
ATM vs ATM30* ATM
ATM30
Two sample t test P
ATM vs ATM60* ATM
ATM60
Two-way ANOVA a
for experiment, P 
ATM vs ATM120* ATM
ATM120
Two-way ANOVA a
for experiment, P 
ATM, Atmosphere; ANOVA, analysis of variance.
*mm HG.
Table II. Wound edge nuclear fluorescence results
Group
ATM vs ATM30* ATM
ATM30
Two sample t test P
ATM vs ATM60* ATM
ATM60
Two sample t test P
ATM vs ATM120* ATM
ATM120
Two-way ANOVA a
for experiment p0
ATM, Atmosphere; ANOVA, analysis of variance.
*mm Hg.was also decreased in NNF grown under pressure.Although our past work suggested NNF grown under
pressure displayed premature aging phenomenon like those
from patients with chronic venous insufficiency,4,6,7,17 the
blunted replicative response may not be the entire explana-
tion for the delay in wound healing. Raffetto et al18 showed
reduced motility in the dermal fibroblasts from patients
with chronic venous insufficiency and NNF when exposed
to wound fluid from venous ulcers.18 These authors sug-
gested the “microenvironment” of the ulcer was responsi-
ble for decreased motility and premature senes-
cence,5,16,18,19 a conclusion supported by this study and
our previous work.4,6,7,17
The pressurized model system used in this study at-
tempts to replicate the pressure effects on a single cellular
component that may be representative of one component
in the complex environment seen in the patient with
chronic venous insufficiency patients and ulceration. NNF
grown in this model system demonstrate a blunted re-
sponse to wounding compared with cells grown without
increased pressure.We used a range of pressures, right up to
120 mm Hg, though this may be supraphysiologic; how-
ever, abnormalities in this study and others were still de-
tected at the lowest pressure used (30 mm Hg).
By using only a single cell type (fibroblasts), we were
n Mean  SD
7 118  76
10 60  31
12 141  84
12 105  94
ng
24 108  50
24 90  45
ng
n Mean  SD
3 159  3
3 83  6
01
3 211  11
3 174  14
6 135  80
6 116  31
ing .10
djusti
.0001
djusti
.02 .00
 .02
djust
.5able to closely study that crucial wound healing element of
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ment described by Raffetto.18 It is likely that many ele-
ments in the venous ulcer microenvironment influence
dermal tissue elements and create the soft-tissue effects of
chronic venous insufficiency. In this work and in the works
of Raffetto et al,18 single cell cultures have been chosen to
investigate the effect of one variable (pressure) on the
healing tendencies of dermal fibroblasts. Future studies
need to focus on the mechanistic effects of pressure and its
resultant delayed response to wounding, while replicating
the clinical wound environment.
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